Bio-Techne Corp
NASDAQ:TECH

  • LAST PRICE
    76.8800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    61.6700/ 1
  • Ask / Lots
    76.8600/ 1
  • Open / Previous Close
    0.0000 / 76.8800
  • Day Range
    ---
  • 52 Week Range
    51.7900
    89.9100
  • Volume
    10

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
TECH
Bio-Techne Corp
12.2B
61.1x
+23.61%
SRPT
Sarepta Therapeutics Inc
11.3B
1,569.0x
---
MEDP
Medpace Holdings Inc
12.5B
40.2x
+35.10%
NBIX
Neurocrine Biosciences Inc
13.5B
37.4x
+62.04%
INSM
Insmed Inc
10.1B
-11.8x
---
QGEN
Qiagen NV
9.8B
28.4x
+12.66%
As of 2024-06-14

Company Information

Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Contact Information

Headquarters
614 MCKINLEY PL N EMINNEAPOLIS, MN, United States 55413
Phone
612-379-8854
Fax
612-656-4400

Executives

Independent Chairman of the Board
Robert Baumgartner
Chief Executive Officer, Chief Operating Officer, Director
Kim Kelderman
Chief Financial Officer, Executive Vice President - Finance
James Hippel
President - Protein Sciences Segment
William Geist
President - Diagnostics and Genomics Segment
Matthew Mcmanus

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$12.2B
Revenue (TTM)
$1.2B
Shares Outstanding
157.6M
Dividend Yield
0.42%
Annual Dividend Rate
0.3200 USD
Ex-Dividend Date
05-10-24
Pay Date
05-24-24
Beta
1.30
EPS
$1.26
Book Value
$12.47
P/E Ratio
61.1x
Price/Sales (TTM)
10.6
Price/Cash Flow (TTM)
38.9x
Operating Margin
22.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.